Risk factor analysis and predictive model development for secondary failure of platelet recovery following allogeneic hematopoietic stem cell transplantation.

IF 3.4 2区 医学 Q2 ONCOLOGY
Xiru Peng, Juan Cheng
{"title":"Risk factor analysis and predictive model development for secondary failure of platelet recovery following allogeneic hematopoietic stem cell transplantation.","authors":"Xiru Peng, Juan Cheng","doi":"10.1186/s12885-025-14653-4","DOIUrl":null,"url":null,"abstract":"<p><p>Secondary failure of platelet recovery (SFPR) is a common complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT), occurring in approximately 20% of cases, and is closely associated with poor patient prognosis. The purpose of this study is to analyze the risk factors associated with SFPR following allo-HSCT, develop a nomogram-based predictive model for SFPR, and validate its accuracy. Clinical data of patients who underwent allo-HSCT in the Department of Hematology at the First Hospital of Lanzhou University from January 2016 to December 2023 were collected. Variables with P < 0.05 in univariate analysis were included in a logistic multivariate stepwise regression to identify the final variables for the model. An SFPR nomogram prediction model was developed using R software and internally validated using the Bootstrap method. The accuracy of the prediction model was assessed through receiver operating characteristic(ROC) and calibration curves, while decision curve analysis evaluated its clinical predictive performance. Based on the body mass index(BMI), chromosome karyotype, transplant type, acute graft-versus-host disease(aGVHD) and post-transplant Interleukin-6(IL-6) and Procalcitonin(PCT), the predicted area under the ROC curve of SFPR is 0.778 (95% CI 0.697-0.858). The absolute error between the predicted risk of SFPR and the actual risk is 0.019. The SFPR nomogram prediction model developed in this study exhibits high accuracy and excellent predictive efficiency, thereby possessing significant clinical guidance value.</p>","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":"25 1","pages":"1233"},"PeriodicalIF":3.4000,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12309133/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12885-025-14653-4","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Secondary failure of platelet recovery (SFPR) is a common complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT), occurring in approximately 20% of cases, and is closely associated with poor patient prognosis. The purpose of this study is to analyze the risk factors associated with SFPR following allo-HSCT, develop a nomogram-based predictive model for SFPR, and validate its accuracy. Clinical data of patients who underwent allo-HSCT in the Department of Hematology at the First Hospital of Lanzhou University from January 2016 to December 2023 were collected. Variables with P < 0.05 in univariate analysis were included in a logistic multivariate stepwise regression to identify the final variables for the model. An SFPR nomogram prediction model was developed using R software and internally validated using the Bootstrap method. The accuracy of the prediction model was assessed through receiver operating characteristic(ROC) and calibration curves, while decision curve analysis evaluated its clinical predictive performance. Based on the body mass index(BMI), chromosome karyotype, transplant type, acute graft-versus-host disease(aGVHD) and post-transplant Interleukin-6(IL-6) and Procalcitonin(PCT), the predicted area under the ROC curve of SFPR is 0.778 (95% CI 0.697-0.858). The absolute error between the predicted risk of SFPR and the actual risk is 0.019. The SFPR nomogram prediction model developed in this study exhibits high accuracy and excellent predictive efficiency, thereby possessing significant clinical guidance value.

异基因造血干细胞移植后继发性血小板恢复失败的危险因素分析及预测模型的建立。
继发性血小板恢复失败(SFPR)是同种异体造血干细胞移植(allogenic hematopoietic stem cell transplantation, alloo - hsct)后常见的并发症,发生率约为20%,且与患者预后不良密切相关。本研究的目的是分析同种异体造血干细胞移植后发生SFPR的相关危险因素,建立基于图的SFPR预测模型,并验证其准确性。收集2016年1月至2023年12月在兰州大学第一医院血液科行同种异体造血干细胞移植患者的临床资料。带P的变量
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Cancer
BMC Cancer 医学-肿瘤学
CiteScore
6.00
自引率
2.60%
发文量
1204
审稿时长
6.8 months
期刊介绍: BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信